Glaukos Corp (GKOS)
151.22
+2.86
(+1.93%)
USD |
NYSE |
Dec 24, 16:00
Glaukos Cash from Investing (Quarterly): 30.56M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
Globus Medical Inc | -14.97M |
Boston Scientific Corp | -1.427B |
Intuitive Surgical Inc | -1.413B |
Masimo Corp | -13.50M |
Stryker Corp | -2.172B |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -9.586M |
Cash from Financing (Quarterly) | 9.668M |
Free Cash Flow | -81.27M |
Free Cash Flow Per Share (Quarterly) | -0.2005 |
Free Cash Flow to Equity (Quarterly) | -11.10M |
Free Cash Flow to Firm (Quarterly) | -11.04M |
Free Cash Flow Yield | -1.05% |